InvestorsHub Logo
Followers 33
Posts 2837
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Tuesday, 04/25/2023 4:44:27 PM

Tuesday, April 25, 2023 4:44:27 PM

Post# of 151
(OT) Dr. Rezvani presented some early, but impressive data showing activity with an CD70-targeted CAR-NK cell therapy in a patient with R/R cHL, from a basket trial for R/R haematological malignancies. A trial in solid tumours should be starting soon.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTX News